Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-25 @ 6:44 PM
Study NCT ID:
NCT01520558
Status:
UNKNOWN
Last Update Posted:
2017-06-29
First Post:
2012-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CNDO-109-AANK for AML in First Complete Remission (CR1)
Sponsor:
Coronado Biosciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CNDO109-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None